Novartis (NVS)

Add to Watchlists Create an Alert
74.62 -0.01  -0.01%   NYSE May 22, 8:00PM BATS Real time Currency in USD

Novartis Shareholders Equity:

67.03B for March 31, 2013
View Full Chart

Novartis Shareholders Equity Chart

    Novartis Historical Shareholders Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 67.03B
    Dec. 31, 2012 69.09B
    Sept. 30, 2012 67.08B
    June 30, 2012 64.13B
    March 31, 2012 63.10B
    Dec. 31, 2011 65.84B
    Sept. 30, 2011 66.14B
    June 30, 2011 67.09B
    March 31, 2011 65.34B
    Dec. 31, 2010 63.20B
    Sept. 30, 2010 66.22B
    June 30, 2010 55.82B
    March 31, 2010 55.22B
    Dec. 31, 2009 57.39B
    Sept. 30, 2009 53.31B
    June 30, 2009 50.49B
    March 31, 2009 46.23B
    Dec. 31, 2008 50.29B
    Sept. 30, 2008 50.74B
    June 30, 2008 51.60B
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
       
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    June 30, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    June 30, 2000 Go Pro

    About Shareholders' Equity

    Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
    Learn More

    Get data for

    NVS Shareholders Equity Benchmarks

    Companies
    Sanofi
    Pfizer
    GlaxoSmithKline 10.17B

    NVS Shareholders Equity Rankings

    Overall 99th percentile
    40 of 8005
    Sector 99th percentile
    1 of 686 in Healthcare
    Industry 98th percentile
    1 of 55 in Drug Manufacturers - Major

    NVS Shareholders Equity Range, Past 5 Years

    Minimum 46.23B Mar 2009
    Maximum 69.09B Dec 2012
    Average 59.77B